Dyne Therapeutics (DYN) Enterprise Value (2019 - 2026)

Dyne Therapeutics' Enterprise Value history runs 8 years deep, the most recent figure standing at -$972.2 million for Q1 2026.

• In Q1 2026, Enterprise Value fell 43.49% year-over-year to -$972.2 million; the TTM figure through Mar 2026 stood at -$972.2 million (down 43.49% YoY), while the FY2025 annual figure was -$1.1 billion, down 72.91% from the prior year.
• Enterprise Value was -$972.2 million for Q1 2026 at Dyne Therapeutics, up from -$1.1 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$123.1 million in Q4 2023 to a low of -$1.1 billion in Q4 2025.
• Historically, Enterprise Value has averaged -$505.5 million across 5 years, with a median of -$453.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Enterprise Value surged 51.92% in 2023, then slumped 421.74% in 2024.
• A 5-year view of Enterprise Value shows it stood at -$256.0 million in 2022, then soared by 51.92% to -$123.1 million in 2023, then plunged by 421.74% to -$642.3 million in 2024, then slumped by 72.91% to -$1.1 billion in 2025, then gained by 12.46% to -$972.2 million in 2026.
• The last three Enterprise Value figures came in at -$972.2 million (Q1 2026), -$1.1 billion (Q4 2025), and -$791.9 million (Q3 2025), per Business Quant data.